About Neopharma
Neopharma is a Healthcare company based in Abu Dhabi (United Arab Emirates) founded in 2003. Global manufacturer of pharmaceutical products, APIs, and formulations for distribution. It operates on a B2B model. The company has 43 employees. Neopharma has completed 1 acquisition, including KYOWA CritiCare. Its website neopharma.com draws about 681 thousand monthly visits. Its Indian entity Neo Pharma Private Limited reported revenue of ₹18.44 Cr. Neopharma offers products and services including API Manufacturing, Finished Products, and Therapies. Its focus areas include Pharmaceuticals, Distribution, Global Supply and Manufacturing.
Company details
Neopharma, founded in 2003, is a global pharmaceutical company with manufacturing facilities across three continents and offices in over 50 countries. It produces branded and generic formulations, as well as active pharmaceutical ingredients, focusing on high-quality, affordable medications through innovation and distribution networks. The company emphasizes commitment, excellence, and integrity in healthcare delivery, serving markets via partnerships and global supply chains from locations like Abu Dhabi.
- Headquarters Abu Dhabi, United Arab Emirates
- Employees 43
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Email••••••••
- Website neopharma.com
- Social LinkedIn X Facebook Instagram
- Legal Name Neo Pharma Private Limited
- Date of Incorporation 09 Mar, 1950
- Jurisdiction Mumbai, Maharashtra, India
- Indian entity revenue₹18.44 Cr
FY 2025 · -32% YoY
- Indian entity net loss-₹14.31 Cr
FY 2025 · -78% margin
- Indian entity EBITDA-₹30.09 Cr
FY 2025 · -163% margin
- Employee Count43
- Investments & Acquisitions
Associated legal entities of Neopharma
Neopharma operates through Neo Pharma Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Neo Pharma Private Limited CIN U24239MH1950PTC008016 | Active | 09 Mar 1950 | Mumbai, Maharashtra | ₹18.4 Cr | 43 | 2 | View details |
Products & Services of Neopharma
Neopharma offers a comprehensive portfolio of products and services, including API Manufacturing, Finished Products, and Therapies.
Production of active pharmaceutical ingredients for global use.
Creation of branded and generic pharmaceutical formulations worldwide.
Development and supply of therapeutic solutions for various needs.
Board of directors of Neo Pharma Private Limited (Neopharma)
Neo Pharma Private Limited is the primary company behind Neopharma. The board of Neo Pharma Private Limited currently have 2 directors; the longest-serving is Jayant Chaganlal Oswal, appointed in 2015. 9 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Jayant Chaganlal Oswal DIN 02102884 | Director | 28 Mar 2015 | 11 yrs 7 mo | Neo Pharma Private Limited |
| Nikunj Pravinchandra Pandya DIN 10725692 | Additional Director | 18 Apr 2025 | 1 yr 6 mo | Neo Pharma Private Limited |
People of Neopharma
13 people are tracked at Neopharma (2 in leadership, 11 in team); the tracked headcount is 43.
| Name | Role | Group |
|---|---|---|
Mukesh Gupta | VP Production | Leadership |
Dr. B. R. Shetty | Founder And Chairman | Leadership |
Virendra Narendra Ghosalkar | Production Executive | Team |
Hari Nair | Lab In Charge | Team |
Unnikrishnan Pk | Area Manager | Team |
Umair Shafi Ullah | Marketing Executive | Team |
Mahmoud Neinaa | Senior Medical Representative | Team |
Rahul Rajeev | Finance Manager | Team |
Abhijith Pv | Executive Engineer | Team |
Fahad Ansari | Area Sales Manager | Team |
Bassant Omar | Summer Intern | Team |
Tamela Tucker | Technical Documentation Analyst | Team |
Manoj Saxena | Supervisor | Team |
Complete people profiles for Neopharma
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Neopharma
Figures of Neo Pharma Private Limited, the primary company behind Neopharma, for FY 2025. Revenue was ₹18.44 Cr (-32% year on year). Net loss was -₹14.31 Cr (-78% margin). EBITDA was -₹30.09 Cr (-163% margin). Revenue has grown at a compounded annual rate of -59% over three years and -34% over five years.
- ₹18.44 CrRevenue · FY 2025 · -32% YoY
- -₹14.31 CrNet loss · -78% margin
- -₹30.09 CrEBITDA · -163% margin
- ₹60.2 LakhPaid-up capital
- 43Employees (provident fund records)
- -59%Revenue CAGR, 3 years
- -34%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Neo Pharma Private Limited are on its company page.
Detailed financial statements for Neopharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Neopharma
Neopharma has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include KYOWA CritiCare.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Critical care drugs and injections are manufactured by KYOWA CritiCare. | kyowacriticare.co.jp | Atsugi, Japan | 1947 | Aug 2019 | •••• |
Complete acquisition details for Neopharma
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Neopharma
2 dated milestones of Neopharma across 16 years, from founding to its latest funding, stage changes and deals.
- Founded Neopharma is founded.
- Acquisition Acquires KYOWA CritiCare.
Web traffic of Neopharma
The website of Neopharma (neopharma.com) receives about 680.7K visits a month and ranks #9,851,621 among all websites worldwide, #7,786 in Biotechnology and Pharmaceuticals.
- Monthly visits680.7K
▼ 6.7% vs previous month
- Global rank#9,851,621
among all websites
- Category rank#7,786
Health · Biotechnology and Pharmaceuticals
- Bounce rate32%
- Pages per visit1.7
- Average visit19 sec
- DevicesDesktop 34% · Mobile 66%
Websites whose visitors overlap most with Neopharma. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| falconebiz.com | 100% | 959.8K | #63,970 | View details | |
| tofler.in | 97% | 556K | #105,509 | View details | |
| zaubacorp.com | 96% | 4.9M | #12,689 | View details | |
| tracxn.com | 92% | 2.9M | #16,597 | View details | |
| indiafilings.com | 90% | 2.1M | #29,959 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 40 similar websites and full traffic analytics for Neopharma
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Neopharma
Complete news archive for Neopharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Neopharma
Neopharma was founded in 2003.
Neopharma is headquartered in Abu Dhabi, United Arab Emirates. It is registered at Abu Dhabi, Abu Dhabi, United Arab Emirates.
Neopharma has 43 employees.
The primary company behind Neopharma, Neo Pharma Private Limited, reported revenue of ₹18.44 Cr for FY 2025, down 32% year on year.
Neopharma, founded in 2003, is a global pharmaceutical company with manufacturing facilities across three continents and offices in over 50 countries. It produces branded and generic formulations, as well as active pharmaceutical ingredients, focusing on high-quality, affordable medications through innovation and distribution networks. The company emphasizes commitment, excellence, and integrity in healthcare delivery, serving markets via partnerships and global supply chains from locations like Abu Dhabi.
Neopharma offers API Manufacturing, Finished Products, and Therapies.
Neopharma has made 1 acquisition, including KYOWA CritiCare.
Neopharma operates through Neo Pharma Private Limited.
The legal entities of Neopharma currently have 2 directors, including Jayant Chaganlal Oswal, Nikunj Pravinchandra Pandya.
The website of Neopharma receives about 681 thousand visits a month and ranks #9,851,621 among all websites worldwide.